HBIOHarvard Bioscience Inc

CSNasdaq (XNAS)·USD

Identity

Security key: 16408
Ticker: HBIO
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2000-12-07
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: HBIO

Detail

Enriched 2026-08-14 20:47

Market cap: $28,087,721.85
Shares outstanding (class): 4,510,182
Shares outstanding (weighted): 4,552,305
SIC: 3826 LABORATORY ANALYTICAL INSTRUMENTS
Employees: 339
Location: HOLLISTON, MA
Homepage: https://www.harvardbioscience.com
Description: Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Market cap and share counts drift.

Funds holding this security

5 funds · 5 positions · $860.9K reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$601.3K	0.00%	123,470 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$194.0K	0.00%	39,843 NS	FIGI
ACUITAS US MICROCAP FUND FORUM FUNDS II	—	$42.8K	0.04%	8,783 NS	FIGI
Gabelli Global Mini Mites Fund GAMCO Global Series Funds, Inc	—	$19.5K	0.09%	4,000 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	$3.3K	0.00%	683 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERHBIO
FIGI_COMPOSITEBBG000C58Q08
FIGI_SHARE_CLASSBBG001SG1ML8
CIK0001123494
ISINUS4169062043
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Life Sciences Tools
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Harvard Bioscience manufactures laboratory analytical instruments for life science research, fitting the healthcare life science tools category.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.